Follow
Javier Tomás Solera Rallo
Javier Tomás Solera Rallo
Other namesSolera JT, Solera J
Chief Fellow, Ajmera Transplant Centre, University Health Network, Toronto, Canada
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Impact of vaccination and early monoclonal antibody therapy on coronavirus disease 2019 outcomes in organ transplant recipients during the Omicron wave
JT Solera, BG Árbol, A Alshahrani, I Bahinskaya, N Marks, A Humar, ...
Clinical Infectious Diseases 75 (12), 2193-2200, 2022
472022
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA. 2 wave
JT Solera, BG Árbol, I Bahinskaya, N Marks, A Humar, D Kumar
American Journal of Transplantation 23 (1), 78-83, 2023
282023
Outcomes of SARS-CoV-2 infection in unvaccinated compared with vaccinated solid organ transplant recipients: a propensity matched cohort study
VG Hall, G Al-Alahmadi, JT Solera, T Marinelli, H Cardinal, GVR Prasad, ...
Transplantation 106 (8), 1622-1628, 2022
192022
Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis
L Escolà-Vergé, G Cuervo, A de Alarcón, D Sousa, LV Barca, ...
Clinical Microbiology and Infection 27 (4), 660-664, 2021
162021
Severity of COVID-19 among solid organ transplant recipients in Canada, 2020–2021: a prospective, multicentre cohort study
VG Hall, JT Solera, G Al-Alahmadi, T Marinelli, H Cardinal, C Poirier, ...
Cmaj 194 (33), E1155-E1163, 2022
152022
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
JT Solera, M Ierullo, BG Arbol, F Mavandadnejad, A Kurtesi, F Qi, Q Hu, ...
The Lancet Infectious Diseases 23 (8), e266-e267, 2023
132023
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
VH Ferreira, JT Solera, Q Hu, VG Hall, BG Arbol, W Rod Hardy, R Samson, ...
Nature Communications 13 (1), 4489, 2022
132022
Differential serum neutralisation of Omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab
JT Solera, BG Arbol, VH Ferreira, A Kurtesi, Q Hu, M Ierullo, ...
The Lancet Infectious Diseases 23 (5), 528-530, 2023
102023
The COVID-19 pandemic and adult cardiac transplantation: impact, interventions, and implications
S Chih, BA Clarke, M Albert, CA Buchan, TS Kafil, DH Kim, D Kumar, ...
Canadian Journal of Cardiology 39 (6), 853-864, 2023
32023
Impact of Omicron BA. 1 infection on BA. 4/5 immunity in transplant recipients
VH Ferreira, Q Hu, A Kurtesi, JT Solera, M Ierullo, AC Gingras, D Kumar, ...
American Journal of Transplantation 23 (2), 278-283, 2023
22023
Experiencia del hospital 12 de octubre en el tratamiento de pacientes con endocarditis infecciosa con ceftarolina
EMA Minguijón, JTS Rallo, CV Martín, IF Herrero, MC Flores, SDC Tejido, ...
Cirugía Cardiovascular 27 (4), 168-169, 2020
2020
¿ ES EL TRATAMIENTO ANTITROMBÓTICO (ANTICOAGULANTE Y/O ANTIAGREGANTE) PREVIO UN FACTOR DE RIESGO DE MORTALIDAD Y DE DESARROLLO DE COMPLICACIONES EN LA ENDOCARDITIS INFECCIOSA?
JTS Rallo, FG Román, ÁR Fernández, MP Serrano, SDC Tejido, ...
Cirugía Cardiovascular 27 (4), 158, 2020
2020
Implante de marcapasos sin cables tras infección y extracción de dispositivo intracavitario previo
F Galván-Román, L Domínguez-Pérez, A Sabín-Collado, JT Solera, ...
Cirugía Cardiovascular 26 (2), 128, 2019
2019
INFECCIONES VASCULARES POR COXIELLA BURNETII: Revisión del diagnóstico, tratamiento y seguimiento a través de tres casos clínicos recientes.
JT Solera, S de Cossio, A Reyes, L Domínguez, F Galván, MA Orellana, ...
Cirugía Cardiovascular 26 (2), 130-131, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–14